Auxilium Pharmaceuticals Inc.
40 Valley Stream Parkway
Malvern,
PA 19355
United States - Map
Phone: 484-321-5900
Fax: 484-321-5999
Web Site: http://www.auxilium.com
| Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and primary care physicians primarily in the United States. The company markets Testim, a topical 1% testosterone gel for the treatment of hypogonadism. Its product pipeline also includes XIAFLEX, an injectable collagenase enzyme, which is in Phase III of development for the treatment of Dupuytrens contracture; and in Phase II of development for the treatment of Peyronies Disease and Adhesive Capsulitis. The companys product pipeline also comprises AA4010, which is in Phase I of development for the treatment of overactive bladder using its transmucosal film delivery system; and A Fentanyl, a pain product, which is in Phase I of development. It has agreement with Pfizer, Inc. for the development, commercialization, and supply of XIAFLEX in European and Eurasian countries. The company was founded in 1999 and is headquartered in Malvern, Pennsylvania. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Armando Anido , 51
Chief Exec. Officer, Pres |
$
841.00K | N/A | Mr. James E. Fickenscher , 45
Chief Financial Officer and Principal Accounting Officer |
N/A
| N/A | Ms. Jennifer Evans Stacey Esq., 44
Exec. VP, Gen. Counsel of HR and Sec. |
$
448.00K |
$
111.00K | Mr. Roger D. Graham Jr., 45
Exec. VP of Sales & Marketing |
$
479.00K | N/A | Dr. Jyrki Mattila M.D., Ph.D., 53
Exec. VP of Bus. Devel., Product Devel. & Technical Operations
|
$
476.00K |
$
5.11M |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
0.36 (1.02%) 
Profile
